(IOVA) Iovance - Performance -78.5% in 12m
IOVA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-91.07%
#190 in Peer-Group
Rel. Strength
3.43%
#7400 in Stock-Universe
Total Return 12m
-78.46%
#174 in Peer-Group
Total Return 5y
-93.39%
#140 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 12.28 USD |
| 52 Week Low | 1.66 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 72.20 |
| Buy/Sell Signal +-5 | -0.90 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: IOVA (-78.5%) vs XBI (-12.9%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-0.31% | 59.8% | 74.7% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
4.3% | -9.7% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.02% | -7.68% | 38% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.08% | 26.2% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.29% | -9.49% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.7% | 37.9% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.29% | 46.5% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
0.46% | 28.5% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: IOVA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for IOVA
| Total Return (including Dividends) | IOVA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -16.52% | 4.10% | 4.77% |
| 3 Months | -45.16% | 13.70% | 16.02% |
| 12 Months | -78.46% | -12.86% | 12.44% |
| 5 Years | -93.39% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | IOVA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -61.4% | 52.1% | 90.3% |
| 3 Months | -61.1% | 79.4% | 97.5% |
| 12 Months | -90.7% | -87.4% | 46.4% |
| 5 Years | -81.8% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th7.00 | -19.81% | -20.32% |
| 3 Month | %th3.00 | -51.77% | -52.73% |
| 12 Month | %th14.00 | -75.28% | -80.84% |
| 5 Years | %th30.50 | -91.53% | -96.89% |
FAQs
Does Iovance (IOVA) outperform the market?
No,
over the last 12 months IOVA made -78.46%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.86%.
Over the last 3 months IOVA made -45.16%, while XBI made 13.70%.
Performance Comparison IOVA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
IOVA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 9.5% | -21.3% | -75.6% | -91% |
| US NASDAQ 100 | QQQ | 9.6% | -21.8% | -77.6% | -91% |
| German DAX 40 | DAX | 9.2% | -19.6% | -87.7% | -108% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 8.3% | -21.6% | -80% | -98% |
| Hongkong Hang Seng | HSI | 8.6% | -20.5% | -97.6% | -113% |
| India NIFTY 50 | INDA | 10.9% | -18.1% | -76% | -75% |
| Brasil Bovespa | EWZ | 13.7% | -16.2% | -90.6% | -79% |
IOVA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 10.9% | -20.1% | -78.9% | -102% |
| Consumer Discretionary | XLY | 8.6% | -21.3% | -67.9% | -95% |
| Consumer Staples | XLP | 11.6% | -17% | -74.6% | -86% |
| Energy | XLE | 6.6% | -18.5% | -68% | -79% |
| Financial | XLF | 11% | -21.3% | -77.9% | -102% |
| Health Care | XLV | 9.4% | -16.3% | -64.1% | -72% |
| Industrial | XLI | 9.1% | -22.1% | -81.4% | -100% |
| Materials | XLB | 8.9% | -21.8% | -76.2% | -82% |
| Real Estate | XLRE | 9.8% | -16.7% | -74% | -85% |
| Technology | XLK | 9.6% | -23.7% | -80.7% | -88% |
| Utilities | XLU | 9.5% | -18.5% | -79.6% | -101% |
| Aerospace & Defense | XAR | 8.9% | -23.8% | -95.5% | -125% |
| Biotech | XBI | 5.9% | -20.6% | -65.3% | -66% |
| Homebuilder | XHB | 6.5% | -27.9% | -69% | -76% |
| Retail | XRT | 9.6% | -23.3% | -70.7% | -85% |
IOVA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 8.9% | -12.9% | -61.6% | -75% |
| Natural Gas | UNG | 11.3% | -7.7% | -49.5% | -82% |
| Gold | GLD | 9.4% | -14.3% | -93.5% | -117% |
| Silver | SLV | 5.2% | -22.8% | -97.6% | -103% |
| Copper | CPER | -0.8% | -32.4% | -95.1% | -102% |
IOVA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 10.4% | -16.3% | -70.2% | -75% |
| iShares High Yield Corp. Bond | HYG | 10.1% | -17.8% | -72.6% | -87% |